Xlumena Raises $25M for Endoscopic Device Development
December 04, 2013
Xlumena, an advanced endoscopic devices developer, has closed on $25 million in Series C financing led by Third Point as it pursues FDA clearance for its principal product, the AXIOS Stent and Delivery System.
The company, which develops products that enable minimally invasive, image-guided endoscopic therapy, will use the proceeds to expand international commercialization efforts for its devices, as well as to continue the process of bringing its platform to the U.S. interventional endoscopy community. Xlumena raised $7 million in Series B funding in 2011, procuring an $11.8 million valuation at the time.